Melasma During Pregnancy: Why It Happens & How to Treat It

What Is Pregnancy Melasma?

Melasma (also called chloasma or the "mask of pregnancy") is a chronic acquired hyperpigmentation of the skin characterized by irregular, symmetric brown, tan, or gray-brown patches on sun-exposed areas of the face. During pregnancy, it is driven by the same triggers that affect non-pregnant people — UV exposure and genetic susceptibility — but dramatically amplified by the hormonal environment of gestation.

It is the most common pigmentation change of pregnancy, affecting between 36% and 75% of pregnant women depending on population, geography, skin type, and sun exposure. Women with Fitzpatrick skin phototypes III–VI (olive to dark skin tones) are disproportionately affected due to higher baseline melanocyte activity, though melasma occurs in every skin tone.

The condition is benign — it causes no physical harm — but its psychological impact is well documented. The validated Melasma Quality of Life scale (MelasQoL) shows that the subjective burden of melasma (distress, low self-esteem, social withdrawal) often exceeds what clinical severity measurements would predict.

Why Pregnancy Causes Melasma: The Mechanism

Melanocytes — the pigment-producing cells in the epidermis — are exquisitely sensitive to hormonal signals. During pregnancy, three converging hormonal changes create conditions for their overactivation:

1. Estrogen upregulates melanocortin receptor expression, increases the sensitivity of melanocytes to stimulating hormones, and activates the PDZK1 gene pathway, increasing melanin synthesis.

2. Progesterone contributes to melanocyte stimulation and may modulate estrogen receptor activity in skin cells.

3. Alpha-melanocyte-stimulating hormone (α-MSH) rises progressively through pregnancy, directly binding MC1R receptors on melanocytes and increasing tyrosinase enzyme activity — the rate-limiting step in melanin production.

UV radiation (including visible light and UVA penetrating window glass) acts as a co-trigger. It independently stimulates keratinocytes to release melanocyte-stimulating factors (endothelin-1, stem cell factor, prostaglandins), and in a hormonally sensitized skin environment, even routine UV exposure from daily life — driving, being near windows — can trigger or worsen melasma. This explains why pregnancy melasma follows a seasonal pattern (worse in summer, slightly better in winter) and why facial distribution follows sun exposure patterns.

Who Is at Highest Risk

Several factors markedly increase likelihood:

• Previous pregnancy melasma: Women who developed melasma in a prior pregnancy are approximately 44 times more likely to develop it again
• Family history: 37.6% of affected women had a mother with melasma; 25.9% had an affected sister
• Darker skin types (Fitzpatrick III–VI): higher baseline melanocyte activity
• High sun exposure and outdoor occupations
• Older maternal age at first pregnancy: risk increases approximately 8% per additional year
• Multiple pregnancies (multiparous women face greater cumulative risk)
• Thyroid dysfunction and autoimmunity
• Zinc deficiency (found in 45.8% of melasma patients in one population study)

How Melasma Looks and Where It Appears

Melasma produces patches that are:

• Color: Tan, medium-brown, dark brown, or gray-brown (the gray-blue variant reflects deeper dermal melanin deposition)
• Texture: Flat, not raised, not scaly
• Distribution: Symmetrically bilateral — the same pattern appears on both sides of the face
• Location: Most commonly cheeks, forehead, nose bridge, upper lip (cutaneous lip, not the vermilion), and chin; occasionally the forearms and neck

Three facial distribution patterns are recognized:

• Centrofacial (most common): affects the forehead, cheeks, nose, and upper lip
• Malar: limited to the cheeks and nose
• Mandibular: along the jawline (less common in pregnancy)

The linea nigra — the dark vertical line from pubic area to umbilicus that also appears in pregnancy — reflects the same hormonal melanocyte stimulation, but in a different distribution.

Diagnosis

Melasma is a clinical diagnosis — a dermatologist assesses by appearance under natural light and may use a Wood's lamp (UV light) to classify depth:

• Epidermal melasma: The dark pigment is in the epidermis; appears more defined and darker under Wood's lamp; responds better to topical treatment
• Dermal melasma: Melanin has migrated into the dermis; appears bluish-gray; responds more slowly and partially to topicals
• Mixed (most common): Both epidermal and dermal components

This classification matters because it predicts treatment response. Dermal melasma responds poorly to topical depigmenting agents alone; epidermal melasma responds much better.

Any new facial pigmentation in pregnancy should be evaluated by a clinician to exclude melanoma. Melanoma in pregnancy is rare but does occur, and any irregular, rapidly changing, or asymmetric lesion warrants urgent dermatology review rather than self-treatment.

Treatment During Pregnancy: What's Safe

Treatment of melasma during pregnancy is intentionally conservative. The hormonal driver continues throughout gestation, making complete resolution difficult regardless of treatment. Most dermatologists recommend prevention and maintenance during pregnancy, reserving more aggressive treatments for postpartum.

The Most Important Intervention: Rigorous Photoprotection

A 2024 study in PMC (PMC11490249) found that consistent broad-spectrum sunscreen use starting in the first trimester could reduce melasma incidence during pregnancy by over 90% in at-risk women. No other single intervention comes close to this prevention magnitude.

For sunscreen during pregnancy:

• Mineral filters only: Zinc oxide and/or titanium dioxide — minimal systemic absorption, no endocrine disruption concerns. Chemical filters oxybenzone and octinoxate should be avoided during pregnancy.
• Tinted formulations with iron oxide: Regular UV filters block UVA and UVB but not visible light, which independently triggers melanogenesis. Iron-oxide-pigmented (tinted) sunscreens block visible light and are particularly effective for melasma management.
• SPF 50+: The 2024 photoprotection-in-pregnancy review recommends SPF ≥50 with PPD (UVA protection factor) of 20–30
• Reapply every 2 hours outdoors, and reapply after swimming or sweating
• Pair with a wide-brimmed hat and seek shade during peak UV hours (10am–4pm)

Broad-spectrum SPF is both the most effective prevention tool and a core treatment adjunct that amplifies every topical treatment listed below.

Azelaic Acid (10–20%)

The most effective topical treatment safe for all trimesters of pregnancy. Azelaic acid inhibits tyrosinase, reduces abnormal melanocyte activity, and has anti-inflammatory properties.

Evidence: A 2022 review of melasma treatments (PMC9464276) reports approximately 50% reduction in MASI scores after 8 weeks of twice-daily 20% azelaic acid cream. It is explicitly described as "safe for use in pregnant and breastfeeding patients" in multiple pregnancy dermatology guidelines.

Application: Apply to affected areas twice daily, morning and evening, after cleansing. Mild stinging or tingling is common on application, typically diminishing after a few weeks.

Available at 10% OTC and as 15% gel (Finacea) or 20% cream (Azelex) by prescription.

Niacinamide (4–5%)

Niacinamide inhibits the transfer of melanosomes (melanin-containing packages) from melanocytes to keratinocytes — a mechanism that is distinct from tyrosinase inhibition and complements azelaic acid. A 2022 review found 4–5% niacinamide cream achieved 62% hemi-MASI reduction after 8 weeks. It is safe throughout pregnancy and breastfeeding.

Use morning and/or evening; combine with vitamin C in the morning for additive brightening effect.

Vitamin C (L-ascorbic Acid, 10–20%)

Vitamin C inhibits tyrosinase, reduces reactive oxygen species generated by UV exposure, and works synergistically with topical photoprotection. The AAD includes it in its pregnancy-safe morning skincare recommendation. Use at 10–20% L-ascorbic acid, applied in the morning before sunscreen.

Kojic Acid

An antifungal-derived ingredient that inhibits tyrosinase. It is included in some pregnancy-safe brightening recommendations (PMC11497768), though evidence is less robust than azelaic acid or niacinamide. Use at 1–4% in a leave-on formulation; some individuals experience contact sensitization.

What to Avoid During Pregnancy

The Postpartum Picture

Approximately 70% of pregnancy-related melasma resolves spontaneously in the months after delivery as hormone levels normalize. However:

• 30% of cases persist 10 years after delivery (PMC11490249), particularly when sun protection has been inconsistent
• Melasma frequently recurs in subsequent pregnancies, especially in those with a prior history
• Oral contraceptives containing estrogen can trigger or perpetuate melasma postpartum — progestin-only or non-hormonal contraception may be preferable for women with persistent melasma

Postpartum Treatments (Not Available During Pregnancy)

Once breastfeeding is complete, more effective treatments become accessible:

• Hydroquinone (2–4%): The established first-line depigmenting agent; 30–40% MASI reduction after 8 weeks, 45–55% at 16 weeks
• Triple combination cream (tretinoin 0.05% + hydroquinone 4% + fluocinolone acetonide 0.01%): The most evidence-backed prescription melasma treatment, producing 50–60% MASI reduction
• Tranexamic acid (oral 250 mg twice daily, 2–4 months): 49% MASI reduction in controlled trials
• Chemical peels (glycolic acid, superficial TCA)
• Microneedling combined with topical treatment: 48% mMASI reduction
• Q-switched Nd:YAG laser in low-fluence toning mode; picosecond lasers

These treatments can clear or significantly fade melasma that persisted through pregnancy. A dermatologist can guide the optimal sequence based on skin type and melasma depth.

Emotional Impact and Practical Coping

The psychological burden of melasma during pregnancy is real and documented. Practical strategies that help:

• Mineral makeup and tinted SPF: A good tinted mineral SPF doubles as light cosmetic coverage; a fuller-coverage mineral foundation can be layered. Color-correcting concealers (peach or orange-toned, applied before foundation) can neutralize brown patches effectively.
• Manage expectations: Treatment during pregnancy addresses progression and severity, not full clearance. The goal is to minimize worsening so postpartum treatments start from a better baseline.
• Continued sunscreen after delivery: Sun exposure will re-trigger melasma even after hormones have normalized — sun protection is a permanent strategy, not a pregnancy-only measure.
• Seek support: If melasma is significantly affecting confidence or quality of life during pregnancy, discuss this with your obstetrician and consider a dermatology referral for a personalized management plan.